Scribe Therapeutics SCTX
NASDAQ SCTX
$16.86 -0.50 (-2.88%)
At close: Nov 11, 2026 · 4:00 PM EST

Scribe Therapeutics (SCTX) Ending Cash Balance (2024 - 2026)

Analysis

Scribe Therapeutics (SCTX) Ending Cash Balance (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 16.91 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 7.94 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.88 Bn
10 Scribe Therapeutics 43.14 Mn 143,663.76 - 36.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 36.26 Mn
Mar 31, 2026 21.06 Mn
Dec 31, 2025 13.47 Mn
Jun 30, 2025 16.66 Mn
Mar 31, 2025 20.57 Mn
Dec 31, 2024 13.28 Mn
API Access

Scribe Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=SCTX&period=max&api_key=YOUR_API_KEY